Epipen Competitor Auvi-q To Return To Market, Promising Lower Costs For Patients

The main competitor to the EpiPen will be sold again in first half of next year, its maker says. Like Epipen, the shot, called Auvi-Q, can deliver a lifesaving jolt of the drug epinephrine to stop a severe allergic reaction. It was removed from the market last year because of [...]

Topics:  epipen   auvi-q   epipen   competitor   market   year   
BING NEWS:
  • EpiPen antitrust lawsuit rebuffed by 10th Circuit
    Those discounts didn't exactly make the EpiPen cheap; but Sanofi argued that they lured insurers into exclusive arrangements with Mylan, requiring them to cover EpiPen and not the newer, Sanofi-made ...
    07/29/2022 - 11:24 am | View Link
  • 10th Circuit asked to revive EpiPen monopoly claims for jury to decide
    After struggling to gain a foothold in the market, Sanofi discovered a defect that might prevent Auvi-Q devices from delivering the drug as needed and recalled the product in October 2015. Rather than ...
    01/19/2022 - 7:04 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News